MedPath

The Use of STOPP/START Criteria for Medication Intervention Among Elderly Population Living in a Geriatric Hospital

Not Applicable
Completed
Conditions
Adverse Drug Effects
Interventions
Other: STOPP/START screening tools for medication intervention
Registration Number
NCT01602744
Lead Sponsor
Wolfson Medical Center
Brief Summary

The purpose of this study is to determine if the use of STOPP/START criteria (STOPP-screening tool of older persons potentially inappropriate prescriptions START-screening tool to alert doctors to right treatment)for medication intervention in elderly population living in a geriatric hospital will lower the number of falls,hospitalization,will improve functioning, quality of life and reduce financial costs.

Detailed Description

Inappropriate prescribing is common in older people and is associated with adverse drug effects,hospitalization and falls. In this trial we want to check the efficacy of the screening tools STOPP/START which were developed and validated in order to reduce inappropriate prescribing. STOPP comprises of 65 indicators of drug-drug, drug-disease interactions and therapeutic duplication. START incorporates 22 evidence based indicators of common prescribing omissions. We will conduct a randomized controlled trial to test the hypothesis that screening the medications of older patients living permanently in a geriatric hospital will improve their quality of life. The compliance of the doctor working in the geriatric hospital to the recommendations of the screening tools will also be checked.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
382
Inclusion Criteria
  • age over 65
  • live in the geriatric hospital "Givaat Hashlosha" permanently.
Exclusion Criteria
  • people with a terminal illness that will not live more than a year.
  • people who enter the geriatric hospital for a short while (are not permanent).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention screening medication groupSTOPP/START screening tools for medication interventionSTOPP/START screening tools are used for medication intervention
Primary Outcome Measures
NameTimeMethod
Quality of Life- Mental Component Summaty (MCS)Outcome measures were assessed at the end of the 12 month follow up

Quality of life will be measured by MOS SF-12 Health Survey questionnare. Results are expressed in terms of two meta scores: The Physical Component Summary(PCS) and the Mental Component Summary (MCS). The PCS and MCS scores have a range of 0 to 100, thus scores greater than 50 represent a better than average health status.

FallsAt the end of the 12 month follow up

Average number of falls per year.

HospitalizationsOutcome measures were assessed at the end of the 12 month follow up

The average number of hospitalizations per year.

SF-12 Health Survey questionnaire-the Physical Component Summary (PCS)Outcome measures were assessed at the end of the 12 month follow up

Quality of life was assessed by the SF-12 Health Survey questionnare. Results are expressed in terms of two meta scores:the Physical Component Summary (PCS) AND Mental Component Summary (MCS). The PCS and MCS scores have a range of 0 to 100, thus scores greater than 50 represent a better than average health status.

Functional Independence Measure (FIM)Outcome measures were assessed at the end of the 12 month follow up

Functioning was assessed by the FIM score. The FIM rates 18 activities of daily living on a 7 point scale ranging from fully dependent (=1) to independent (=7). A maximum score of 126 indicates functional independence and the lowest score of 18 indicates functional dependence.

Secondary Outcome Measures
NameTimeMethod
Pharmacoeconomics Analysis-Costs of MedicationOutcome measures were assessed at the end of the 12 month follow up

The costs on medications in the geriatric hospital before and after intervention e.g. pharmaeconomic analysis of the intervention. Costs of medications were calculated in New Israeli shekels per month and taken from the Ministry of Health's medication price list.

Trial Locations

Locations (1)

Givaat Hashlosha Geriatric Hospital

🇮🇱

Petach Tikva, Israel

© Copyright 2025. All Rights Reserved by MedPath